Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

10x Genomics (TXG) Interest Expenses (2018 - 2025)

10x Genomics' Interest Expenses history spans 8 years, with the latest figure at -$3000.0 for Q3 2025.

  • For Q3 2025, Interest Expenses fell 250.0% year-over-year to -$3000.0; the TTM value through Jun 2025 reached $5000.0, down 54.55%, while the annual FY2024 figure was $4000.0, 87.88% down from the prior year.
  • Interest Expenses for Q3 2025 was -$3000.0 at 10x Genomics, down from $3000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $221000.0 in Q1 2021 and bottomed at -$3000.0 in Q3 2025.
  • The 5-year median for Interest Expenses is $19000.0 (2023), against an average of $81117.6.
  • The largest YoY upside for Interest Expenses was 200.0% in 2025 against a maximum downside of 250.0% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $217000.0 in 2021, then plummeted by 42.4% to $125000.0 in 2022, then crashed by 93.6% to $8000.0 in 2023, then crashed by 75.0% to $2000.0 in 2024, then tumbled by 250.0% to -$3000.0 in 2025.
  • Per Business Quant, the three most recent readings for TXG's Interest Expenses are -$3000.0 (Q3 2025), $3000.0 (Q2 2025), and $2000.0 (Q3 2024).